Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transfusion Requirements in Orthopedic Surgery (Phase 2): A Prospective Observational Evaluation of the Optimal Transfusion Trigger.

NCT00726349 is registered in ClinicalTrials.gov with Centre hospitalier de l'Université de Montréal (CHUM) as lead sponsor.

NCT NCT00726349
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00726349 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transfusion Requirements in Orthopedic Surgery (Phase 2): A Prospective Observational Evaluation of the Optimal Transfusion Trigger.
Lead sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
Phase
Observational
Overall status
Completed
Start date
May 31, 2008
Completion date
May 31, 2011
Enrollment
305 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

total hip or knee arthroplasty